AsiaStrategy (SORA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SORA SEC filings page.
AsiaStrategy (SORA) reported $11.0M in revenue for fiscal year 2025, down 37.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported profit in FY2025 came from outside core operations, while shrinking sales and cash outflows reshaped the balance sheet.
FY2025 combined a111.9% net margin with a-14.4% operating margin and operating cash flow of-$4.3M . That combination means headline earnings did not represent cash-generating operations; a very large non-operating or accounting contribution outweighed the underlying operating loss.
Revenue fell from
Assets expanded from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of AsiaStrategy's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
AsiaStrategy has an operating margin of -14.3%, meaning the company loses $14 on every $100 of revenue. This results in a profitability score of 20/100. This is down from 1.3% the prior year.
AsiaStrategy's revenue declined 37.7% year-over-year, from $17.6M to $11.0M. This contraction results in a growth score of 3/100.
AsiaStrategy carries a low D/E ratio of 0.14, meaning only $0.14 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 6.51, AsiaStrategy holds $6.51 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 95/100.
AsiaStrategy's operations used $4.3M of cash, and capex of $5K added to the outflow, for a free cash flow shortfall of $4.3M. This results in a cash flow score of 6/100.
AsiaStrategy's ROE of 56.4% shows moderate profitability relative to equity, earning a score of 36/100. This is up from -3.1% the prior year.
AsiaStrategy scores 3.09, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($51.2M) relative to total liabilities ($17.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
AsiaStrategy passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, AsiaStrategy used $0.35 of operating cash (-$4.3M OCF vs $12.3M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
AsiaStrategy reported an operating loss of $1.6M against $65K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
AsiaStrategy held $1.5M in cash against $3.0M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
SORA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
SORA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2420-F | Q4'2310-K |
|---|---|---|---|---|
| Total Assets | $39.7M+499.4% | $14.2M | $6.6M+19.0% | $5.6M |
| Current Assets | $32.1M+451.7% | $13.3M | $5.8M+26.7% | $4.6M |
| Cash & Equivalents | $1.5M-44.5% | $5.6M | $2.6M+76.3% | $1.5M |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Inventory | $7.1M+228.2% | $3.3M | $2.2M+8.7% | $2.0M |
| Accounts Receivable | $43K | $18K | N/A | $142K |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Total Liabilities | $17.9M+241.1% | $5.3M | $5.3M-14.7% | $6.2M |
| Current Liabilities | $4.9M+143.4% | $2.3M | $2.0M-26.2% | $2.7M |
| Non-Current Liabilities | $13.0M+302.6% | $3.0M | $3.2M-5.5% | $3.4M |
| Long-Term Debt | $3.0M-7.4% | $3.0M | $3.2M-5.5% | $3.4M |
| Total Equity | $21.8M+1487.5% | $8.9M | $1.4M+332.2% | -$592K |
| Retained Earnings | $11.7M+1925.8% | -$1.2M | -$638K-7.1% | -$596K |
Not reported in any period shown, so not listed: Goodwill.
SORA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
SORA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| AsiaStrategy SORA | FY2025 | $11.0M | $12.3M | N/A | $51.2M | 40/100 |
| Envela Corporation ELA | FY2025 | $241.0M | $14.6M | 6.1% | $312.9M | 72/100 |
| Brilliant Earth Group, Inc. BRLT | FY2025 | $437.5M | -$3.6M | -0.8% | $23.7M | 45/100 |
| Lanvin Group Holdings Limited LANV | FY2025 | $78.2M | -$26.0M | -33.2% | $112.3M | — |
| Movado Group, Inc. MOV | FY2026 | $671.3M | $26.6M | 4.0% | $746.3M | 55/100 |
Where AsiaStrategy Ranks
Frequently Asked Questions
What is AsiaStrategy's annual revenue?
AsiaStrategy (SORA) reported $11.0M in total revenue for fiscal year 2025. This represents a -37.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AsiaStrategy's revenue growing?
AsiaStrategy (SORA) revenue declined by 37.7% year-over-year, from $17.6M to $11.0M in fiscal year 2025.
Is AsiaStrategy profitable?
Yes, AsiaStrategy (SORA) reported a net income of $12.3M in fiscal year 2025.
What is AsiaStrategy's EBITDA?
AsiaStrategy (SORA) had EBITDA of -$1.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does AsiaStrategy have?
As of fiscal year 2025, AsiaStrategy (SORA) had $1.5M in cash and equivalents against $3.0M in long-term debt.
What is AsiaStrategy's gross margin?
AsiaStrategy (SORA) had a gross margin of 3.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is AsiaStrategy's operating margin?
AsiaStrategy (SORA) had an operating margin of -14.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is AsiaStrategy's return on equity (ROE)?
AsiaStrategy (SORA) has a return on equity of 56.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is AsiaStrategy's free cash flow?
AsiaStrategy (SORA) recorded an outflow of $4.3M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is AsiaStrategy's operating cash flow?
AsiaStrategy (SORA) recorded an outflow of $4.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are AsiaStrategy's total assets?
AsiaStrategy (SORA) had $39.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are AsiaStrategy's capital expenditures?
AsiaStrategy (SORA) invested $5K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is AsiaStrategy's current ratio?
AsiaStrategy (SORA) had a current ratio of 6.51 as of fiscal year 2025, which is generally considered healthy.
What is AsiaStrategy's debt-to-equity ratio?
AsiaStrategy (SORA) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is AsiaStrategy's return on assets (ROA)?
AsiaStrategy (SORA) had a return on assets of 30.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is AsiaStrategy's P/E ratio?
AsiaStrategy (SORA) trades at 4.2x earnings, its market capitalization divided by net income of $12.3M net income, FY2025. The market capitalization is $51.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AsiaStrategy's price-to-sales ratio?
AsiaStrategy (SORA) trades at 4.7x sales, its market capitalization divided by revenue of $11.0M revenue, FY2025. The market capitalization is $51.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does AsiaStrategy's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, AsiaStrategy (SORA) held $1.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $4.3M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is AsiaStrategy's Altman Z-Score?
AsiaStrategy (SORA) has an Altman Z-Score of 3.09, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is AsiaStrategy's Piotroski F-Score?
AsiaStrategy (SORA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AsiaStrategy's earnings high quality?
For every $1 of reported earnings, AsiaStrategy (SORA) used $0.35 of operating cash (-$4.3M OCF vs $12.3M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can AsiaStrategy cover its interest payments?
AsiaStrategy (SORA) reported an operating loss of $1.6M against $65K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is AsiaStrategy?
AsiaStrategy (SORA) scores 40 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.